Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-11

Clinical Trial Update: ORTHOVISC Shoulder Osteoarthritis Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of ORTHOVISC for glenohumeral osteoarthritis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORTHOVISC (hyaluronic acid)

Snippet

Sponsor: DePuy Mitek | Conditions: Glenohumeral Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-11